What is Solventum's medsurg — total operating income?

Solventum (SOLV) reported medsurg — total operating income of $355M in Q2 2026.

How has Solventum's medsurg — total operating income changed year-over-year?

Solventum's medsurg — total operating income increased by 69.0% year-over-year, from $210M to $355M.

What is the long-term trend for Solventum's medsurg — total operating income?

Over 3 years (2022 to 2025), Solventum's medsurg — total operating income has grown at a -8.6% compound annual growth rate (CAGR), from $1.06B to $810M.

What does medsurg — total operating income mean?

Represents the profit generated by the MedSurg segment after deducting both cost of sales and operating expenses from total net sales. It serves as the primary measure of the segment's core operational profitability.

Solventum (SOLV) MedSurg — Total operating income

Screener

Other segment segments

Health Information Systems

$145M+20.8%

Dental Solutions

$131M+36.5%

Purification and Filtration Segment

$0-100%

Similar metrics at other companies

BWXTCommercial Operations — Total operating income

$24.03M+272%

BWXTGovernment Operations — Total operating income

$99.14M+1.4%

ANDGReportable Segment — Total operating income

$24.08M-54.3%

CPKRegulated Energy — Total operating income

$55.2M+6.6%

CPKUnregulated Energy — Total operating income

-$2.5M-66.7%

HALCompletion And Production — Total operating income

$474M-7.6%

Other financials

Income statement

See full

Revenue$2.2B+2.2%

Gross profit$1.3B+9.4%

Operating income$181.0M-15.4%

Net income$92.0M+2.2%

EPS (diluted)$0.53+3.9%

Balance sheet

See full

Cash & equivalents$403.0M-18.1%

Total debt$5.8B-25.9%

Total equity$4.8B+31.7%

Total assets$14.2B-5.5%

Cash flow

See full

Operating cash flow$227.0M+34.3%

CapEx$83.0M-24.5%

Free cash flow-$273.0M-241%

Valuation

See full

Market cap$15.15B+20.6%

Enterprise value$20.54B+3.3%

P/E10.6×-22.5×

P/S1.8×+0.3×

Profitability

See full

Gross margin54.7%+0.2pp

Operating margin25%+15.7pp

Net margin17.3%+12.7pp

FCF margin4.6%-13.9pp

Returns & leverage

See full

Return on equity34%+22.3pp

Debt / equity1.2×-0.9×

Current ratio1×-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed: Aug 5, 2026, 5:27 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001964738-26-000047

Net Sales (Millions)	Three months ended June 30, 2026	Three months ended June 30, 2025	Six months ended June 30, 2026	Six months ended June 30, 2025
* Operating expenses are comprised of selling, general and administrative expenses and research and development expenses as shown on the condensed consolidated statements of income.
	Three months ended June 30,		Six months ended June 30,
Operating Performance (Millions)	2026	2025	2026	2025
MedSurg	$355	$210	$516	$416
Dental Solutions	131	96	218	175
Health Information Systems	145	120	276	229
Total reportable segment operating income	631	426	1,009	820
Purification and Filtration	—	43	—	70

Item 1. Financial Statements

FAQ

What is Solventum's medsurg — total operating income?: Solventum (SOLV) reported medsurg — total operating income of $355M in Q2 2026.
How has Solventum's medsurg — total operating income changed year-over-year?: Solventum's medsurg — total operating income increased by 69.0% year-over-year, from $210M to $355M.
What is the long-term trend for Solventum's medsurg — total operating income?: Over 3 years (2022 to 2025), Solventum's medsurg — total operating income has grown at a -8.6% compound annual growth rate (CAGR), from $1.06B to $810M.
What does medsurg — total operating income mean?: Represents the profit generated by the MedSurg segment after deducting both cost of sales and operating expenses from total net sales. It serves as the primary measure of the segment's core operational profitability.